![](/img/cover-not-exists.png)
Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients
Mahadevan, D., Mita, Monica, Richards, Donald, McClay, Edward, Heist, Rebecca Suk, Kumar, A., Sundararajan, S., Naing, AungVolume:
79
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-017-3258-0
Date:
April, 2017
File:
PDF, 634 KB
english, 2017